MDMA-Assisted Therapy Co-Therapists (Clinical Delivery)

The contract seeks qualified subcontractors to deliver direct clinical co-therapy services as part of a controlled MDMA-assisted therapy trial targeting Veterans diagnosed with PTSD and Alcohol Use Disorder. Providers must adhere strictly to an approved clinical protocol and comply with all federal regulatory standards governing the use of MDMA in therapeutic settings. Services are to be performed in Providence, Rhode Island, with all sessions conducted under rigorous supervision and documentation requirements to ensure patient safety and data integrity. The work involves collaboration with a multidisciplinary team to support the therapeutic process before, during, and after MDMA sessions, requiring specialized training and experience in trauma-informed care and substance use disorders. This is a Small Business Set Aside under NAICS code 621330, meaning only small business concerns are eligible to compete. The opportunity was posted on July 30, 2026, with a response deadline of August 13, 2026, and is issued under the Department of Veterans Affairs through the 241-NETWORK Contract Office 01. The subcontract will support a federally sanctioned clinical trial, requiring compliance with institutional review board guidelines, DEA regulations, and VA-specific oversight protocols. Successful applicants must demonstrate proven capability in delivering high-fidelity, evidence-based psychotherapeutic interventions in controlled research environments and maintain the highest ethical and operational standards throughout service delivery.